314 related articles for article (PubMed ID: 25184215)
1. Obesity affects the biopsy-mediated detection of prostate cancer, particularly high-grade prostate cancer: a dose-response meta-analysis of 29,464 patients.
Hu MB; Liu SH; Jiang HW; Bai PD; Ding Q
PLoS One; 2014; 9(9):e106677. PubMed ID: 25184215
[TBL] [Abstract][Full Text] [Related]
2. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?
Liang Y; Ketchum NS; Goodman PJ; Klein EA; Thompson IM
J Urol; 2014 Oct; 192(4):1094-9. PubMed ID: 24747090
[TBL] [Abstract][Full Text] [Related]
4. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
5. Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea.
Park J; Cho SY; Lee SB; Son H; Jeong H
BJU Int; 2014 Dec; 114(6):891-5. PubMed ID: 24314095
[TBL] [Abstract][Full Text] [Related]
6. The uncertain relationship between obesity and prostate cancer: an Italian biopsy cohort analysis.
De Nunzio C; Freedland SJ; Miano L; Finazzi Agrò E; Bañez L; Tubaro A
Eur J Surg Oncol; 2011 Dec; 37(12):1025-9. PubMed ID: 21963050
[TBL] [Abstract][Full Text] [Related]
7. Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate.
Rundle A; Jankowski M; Kryvenko ON; Tang D; Rybicki BA
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):898-904. PubMed ID: 23613026
[TBL] [Abstract][Full Text] [Related]
8. Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study.
De Nunzio C; Albisinni S; Freedland SJ; Miano L; Cindolo L; Finazzi Agrò E; Autorino R; De Sio M; Schips L; Tubaro A
Urol Oncol; 2013 Oct; 31(7):997-1002. PubMed ID: 21925906
[TBL] [Abstract][Full Text] [Related]
9. Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies.
Discacciati A; Orsini N; Wolk A
Ann Oncol; 2012 Jul; 23(7):1665-71. PubMed ID: 22228452
[TBL] [Abstract][Full Text] [Related]
10. Body mass index as a predictor of prostate cancer: development versus detection on biopsy.
Freedland SJ; Terris MK; Platz EA; Presti JC
Urology; 2005 Jul; 66(1):108-13. PubMed ID: 15992911
[TBL] [Abstract][Full Text] [Related]
11. Obesity is a significant risk factor for prostate cancer at the time of biopsy.
Freedland SJ; Wen J; Wuerstle M; Shah A; Lai D; Moalej B; Atala C; Aronson WJ
Urology; 2008 Nov; 72(5):1102-5. PubMed ID: 18722650
[TBL] [Abstract][Full Text] [Related]
12. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL.
Fukushima H; Masuda H; Kawakami S; Ito M; Sakura M; Numao N; Koga F; Saito K; Fujii Y; Yamamoto S; Yonese J; Fukui I; Kihara K
Urology; 2012 Jun; 79(6):1329-34. PubMed ID: 22656412
[TBL] [Abstract][Full Text] [Related]
13. The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series.
Moreira DM; Anderson T; Gerber L; Thomas JA; Bañez LL; McKeever MG; Hoyo C; Grant D; Jayachandran J; Freedland SJ
Cancer Causes Control; 2011 Jul; 22(7):977-83. PubMed ID: 21562753
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome increases the risk of aggressive prostate cancer detection.
Morote J; Ropero J; Planas J; Bastarós JM; Delgado G; Placer J; Celma A; de Torres IM; Carles J; Reventós J; Doll A
BJU Int; 2013 Jun; 111(7):1031-6. PubMed ID: 22883053
[TBL] [Abstract][Full Text] [Related]
15. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.
Gong Z; Neuhouser ML; Goodman PJ; Albanes D; Chi C; Hsing AW; Lippman SM; Platz EA; Pollak MN; Thompson IM; Kristal AR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1977-83. PubMed ID: 17035408
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
[TBL] [Abstract][Full Text] [Related]
17. Sedentary Behavior and Prostate Cancer: A Systematic Review and Meta-Analysis of Prospective Cohort Studies.
Berger FF; Leitzmann MF; Hillreiner A; Sedlmeier AM; Prokopidi-Danisch ME; Burger M; Jochem C
Cancer Prev Res (Phila); 2019 Oct; 12(10):675-688. PubMed ID: 31362941
[TBL] [Abstract][Full Text] [Related]
18. Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose-response meta-analysis of 36,927 patients.
Hu MB; Xu H; Bai PD; Jiang HW; Ding Q
Med Oncol; 2014 Feb; 31(2):829. PubMed ID: 24390417
[TBL] [Abstract][Full Text] [Related]
19. Low testosterone level is an independent risk factor for high-grade prostate cancer detection at biopsy.
Park J; Cho SY; Jeong SH; Lee SB; Son H; Jeong H
BJU Int; 2016 Aug; 118(2):230-5. PubMed ID: 26086732
[TBL] [Abstract][Full Text] [Related]
20. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
